Crohns Disease: Clinical Trials

3 trials for Crohns Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Recruiting 1, Unknown 1
Phase 21Unknown 1

Follow Crohns Disease: new trials by email Literature Review of Crohns Disease trials Research Report on Crohns Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Guselkumab - Crohns Disease, Colitis, Ulcerative
Phase 3RecruitingJanssen Research & Development, LLC1962024-10-292026-11-03
A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Guselkumab - Crohns Disease
Phase 3CompletedJanssen Pharmaceutical K.K.382020-06-102026-10-07
Vitamin D Treatment for Crohn´s Disease
Vitamin D - Crohns Disease
Phase 2 / Phase 3UnknownUniversity of Aarhus1102005-09-012007-04-13

Narrower conditions

Crohn Disease (3)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Psoriatic (1)  ·  Colitis, Ulcerative (1)

Broader conditions

Digestive System Diseases (3)  ·  Gastroenteritis (3)  ·  Gastrointestinal Diseases (3)  ·  Inflammatory Bowel Diseases (3)  ·  Intestinal Diseases (3)  ·  Arthritis (1)  ·  Autoimmune Diseases (1)  ·  Bone Diseases (1)  ·  Colitis (1)  ·  Colonic Diseases (1)  ·  Connective Tissue Diseases (1)  ·  Immune System Diseases (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Psoriasis (1)

Interventions

guselkumab (2)  ·  Vitamin D (1)

Sponsors

Janssen Pharmaceutical K.K. (1)  ·  Janssen Research & Development, LLC (1)  ·  University of Aarhus (1)

Countries

Japan (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Norway (1)  ·  Poland (1)  ·  Portugal (1)  ·  South Korea (1)

Top investigators

Jens F. Dahlerup, MD, DrMedSc (1)

NIH funding

2005 (1), 2023 (1)